Abstract:Diagnosis of fetal ICH is amenable to antenatal US. Most of the cases identified are of high grade and usually detected during the third trimester. MRI is a valuable complementary tool in evaluating ICH. Conversely to that previously reported, postnatal survival is high but it entails the risk of adverse neurologic outcome in most neonates.
“…A total of 80 articles describing 240 cases were included 16,17,19–96 . The search of MEDLINE and Embase provided a total of 14 991 records, with three additional records identified by hand searching (Fig.…”
AIM To determine how the severity of antenatally diagnosed germinal matrix-intraventricular hemorrhage (GMH-IVH) relates to morbidity and mortality, and to explore potential risk factors. METHOD We conducted a systematic review and individual patient data meta-analysis of antenatally diagnosed fetal GMH-IVH. The primary outcomes were mortality and morbidity. Potential associations with clinical factors during pregnancy were explored. Analysis employed Fisher's exact test and logistic regression. RESULTS We included 240 cases from 80 studies. Presence of venous infarction was associated with mortality (odds ratio [OR] 4.3, 95% confidence interval [CI] 1.4-13.25), motor impairment (OR 103.2, 95% CI 8.6-1238), epilepsy (OR 6.46, 95% CI 2.64-16.06), and developmental delay (OR 8.55, 95% CI 2.12-48.79). Shunt placement was associated with gestational age at GMH-IVH diagnosis and in utero progression. Many cases had uncomplicated pregnancies but possible co-occurring conditions included twin gestation, small for gestational age, and congenital anomalies. INTERPRETATION Severity of fetal GMH-IVH, specifically venous infarction, is associated with overall mortality and morbidity. Risk factors for fetal GMH-IVH are poorly understood and controlled studies are required.
“…A total of 80 articles describing 240 cases were included 16,17,19–96 . The search of MEDLINE and Embase provided a total of 14 991 records, with three additional records identified by hand searching (Fig.…”
AIM To determine how the severity of antenatally diagnosed germinal matrix-intraventricular hemorrhage (GMH-IVH) relates to morbidity and mortality, and to explore potential risk factors. METHOD We conducted a systematic review and individual patient data meta-analysis of antenatally diagnosed fetal GMH-IVH. The primary outcomes were mortality and morbidity. Potential associations with clinical factors during pregnancy were explored. Analysis employed Fisher's exact test and logistic regression. RESULTS We included 240 cases from 80 studies. Presence of venous infarction was associated with mortality (odds ratio [OR] 4.3, 95% confidence interval [CI] 1.4-13.25), motor impairment (OR 103.2, 95% CI 8.6-1238), epilepsy (OR 6.46, 95% CI 2.64-16.06), and developmental delay (OR 8.55, 95% CI 2.12-48.79). Shunt placement was associated with gestational age at GMH-IVH diagnosis and in utero progression. Many cases had uncomplicated pregnancies but possible co-occurring conditions included twin gestation, small for gestational age, and congenital anomalies. INTERPRETATION Severity of fetal GMH-IVH, specifically venous infarction, is associated with overall mortality and morbidity. Risk factors for fetal GMH-IVH are poorly understood and controlled studies are required.
“…); under these circumstances, an external version can be considered and, if this fails, MRI may be indicated. Sequential follow‐up with third‐trimester neurosonographic assessment could also be considered to diagnose developmental findings that may appear only later in pregnancy but are significant for differential diagnosis and prognostication. Some of the conditions that may go undiagnosed by routine US, such as intracranial hemorrhage (Figures 1 and 2), callosal anomalies (Figure 3) and malformations of cortical development (Figure 4), may be diagnosed by neurosonography and have been reported in several clinical studies 16–23 . The reasons for the diagnostic failure by US of these conditions are not discussed in the ENSO study 15 .…”
Section: Figurementioning
confidence: 99%
“…Following ultrasound diagnosis, additional MRI was performed at 32 + 6 weeks, which also showed IVH (d). reported in several clinical studies [16][17][18][19][20][21][22][23] . The reasons for the diagnostic failure by US of these conditions are not discussed in the ENSO study 15 .…”
“…1 ICH is associated with poor neurologic outcomes in the neonate, including psychomotor delays, cerebral palsy, postnatal seizure disorders, and intellectual disabilities. 2 For these reasons, prenatal diagnosis of ICH is crucial for prenatal counselling, antenatal surveillance, and immediate postnatal neurosurgical evaluation to optimise outcomes and quality of life.…”
Section: Introductionmentioning
confidence: 99%
“…Though the incidence is low, findings of ICH are not usually detected until the second and earlythird trimesters. 2 No cases of first-trimester prenatal diagnosis of ICH have been described. We report a case of a singleton pregnancy in which fetal ICH of unknown aetiology was diagnosed at 13 weeks and 5 days during the first-trimester ultrasound.…”
Fetal intracranial haemorrhage (ICH) is a pathophysiological process involving haemorrhagic and hypoxic-ischaemic insults resulting in antenatal brain damage. Insults to the central nervous system are usually not detected until the second or third trimester. In this case presentation, we present a possible prenatal ultrasound marker, 'worm sign', representing cortical disruption secondary to suspected ICH at 13 weeks' gestation. According to current literature review, this is one of the first cases of ICH, diagnosed in the first-trimester and highlights the importance of early neurovascular and structural evaluation of the fetal brain at the time of first-trimester ultrasound screening.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.